Treatment-related fatal sepsis from topotecan/cisplatin and topotecan/paclitaxel.
Miller
A A
AA
Lilenbaum
R C
RC
Lynch
T J
TJ
Rosner
G L
GL
Ratain
M J
MJ
Green
M R
MR
Schilsky
R L
RL
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D002945:Cisplatin / Q000009:adverse effects; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced*; D017239:Paclitaxel / Q000009:adverse effects; D018805:Sepsis / Q000209:etiology* / Q000276:immunology; D019772:Topotecan
D019772:Topotecan; D017239:Paclitaxel; D002945:Cisplatin; D002166:Camptothecin